Moderna Vaccine in Adolescents In a trial of mRNA-1273 or | UPDATES IN MEDICINE
Moderna Vaccine in Adolescents
In a trial of mRNA-1273 or placebo involving 3700 adolescents 12 to 17 years of age, two doses of vaccine stimulated high levels of neutralizing antibodies, with a side-effect profile similar to that seen in other age groups. The incidence of Covid-19 in the unvaccinated group was too low to gauge protection, but Covid-19 did not develop in any vaccinated participants.
